Washington Post
Moderna announces July clinical trials after experimental coronavirus vaccine shows promising early results
Moderna, the Massachusetts biotechnology company behind a leading effort to create a coronavirus vaccine, announced promising early results from its ...
Viewpoint: Anti-vaxxers are expected to fight a coronavirus vaccine. Here’s one way to deal with them
[T]he race for a [coronavirus] vaccine and the techniques being used to manufacture it are bound to activate some familiar ...
Second massive locust swarm hits East Africa, exacerbating already severe food shortage threat
They’re back: Trillions of locusts descend on East Africa in second wave. Think of locusts as giant, hormonally charged, very ...
Viewpoint: Medical ethics shouldn’t stop coronavirus vaccine researchers from experimenting on healthy people
The pandemic has thrown previous moral assumptions into disarray. ... Research ethics normally prohibits exposing human subjects to significant risk ...
Can we trust coronavirus antibody tests never reviewed by the FDA?
The Food and Drug Administration, criticized for slowness in authorizing tests to detect coronavirus infections, has taken a strikingly different ...
Anti-malarial drug hydroxychloroquine linked to higher death rate in VA coronavirus patient study
An anti-malarial drug President Trump has aggressively promoted to treat covid-19 had no benefit and was linked to higher rates ...
‘It’s a cacophony’: Quest for coronavirus treatments undermined by ‘disorganized and scattershot’ US approach
In a desperate bid to find treatments for people sickened by the coronavirus, doctors and drug companies have launched more ...
‘Failures aren’t for lack of trying’: The quest to find a drug for Alzheimer’s
In February, pharmaceutical companies Roche and Eli Lilly announced that two experimental drugs they had developed for Alzheimer’s disease had ...
Bringing ‘medical lore’ to life: Century-old practice of plasma infusions could be used against coronavirus
An old idea for fighting infections — an approach most physicians know about only from medical lore — is being ...
‘Anecdote and feeling over science and fact’: Exploring President Trump’s embrace of controversial anti-malarial drug
As he stares down a pandemic, economic collapse and a political crisis of his own, President Trump thinks he may ...
Racing for a COVID-19 vaccine doesn’t mean we’ll have one this year
THE CORONA-VACCINE RACE: The desperate search for a vaccine for covid-19, the disease caused by the novel coronavirus, is in ...
‘Deep structural problems’: Examining the US failure to quickly develop a coronavirus test
On a Jan. 15 conference call, a leading scientist at the federal Centers for Disease Control and Prevention assured local ...
DNA tests can guide breast cancer treatment, while also raising questions we can’t yet answer
In a new era of precision medicine, the role of genetics is becoming increasingly critical to determine who might benefit ...
Aging America: In 30 years, 13.8 million people in the US may have Alzheimer’s
Alzheimer’s disease, the most common dementia among older adults, now affects about 5.8 million U.S. residents 65 and older — ...
The coronavirus isn’t mutating quickly. That could mean a one-time vaccination against it
The coronavirus is not mutating significantly as it circulates through the human population, according to scientists who are closely studying ...
Promising coronavirus treatment effort blocked by fetal tissue research ban
A senior scientist at a government biomedical research laboratory has been thwarted in his efforts to conduct experiments on possible ...
‘A new thing to worry about’: Coronavirus adds stress for people with anxiety disorders
For some of the millions of Americans with post-traumatic stress disorder, obsessive-compulsive disorder or other forms of debilitating anxiety, coronavirus ...
We still have time to slow the spread: 4 things to know about the coronavirus
The experts are telling us that here in the United States, we can avoid hitting that threshold where sizable regions ...
If naps don’t work for you, it could be genetics
Naturally, I’ve always been a little jealous of the people who take naps and wake up feeling like a million ...
‘Illusion of causality’ and why we trust our own experiences more than science
Did you cut out sugar and feel more energetic, take vitamin C and stop getting colds, switch to eating only ...
Why this woman played the violin during her brain surgery
Eyes closed, Dagmar Turner ran through scales as doctors huddled behind her to peer into her open brain. A violinist ...
How beer brewers and marijuana growers are teaming up to help address the climate crisis
The state of Colorado and three small businesses are trying a novel approach to reduce carbon emissions that sounds like ...
Viewpoint: How the ‘green lobby’ has partnered with the fishing industry to keep sustainable GMO salmon off our plates for 25 years
What should one make of the following set of facts? A federal government, urged on by self-designated advocates for the ...
Humans are ‘biologically built’ to seek out friends
We humans are biologically built to seek friends, and we can see suggestions of our evolutionary past in the social ...
US life expectancy edges upward as cancer death rate drops
The number of fatal drug overdoses declined for the first time in 28 years, and U.S. life expectancy at birth ticked upward for the ...
Hand sanitizers can’t ‘work miracles’: Purell warned by FDA to cut back on marketing claims
The makers of Purell are pruning their marketing strategy after the Food and Drug Administration slapped the company with a ...
Why the US is ‘not nearly as prepared as we need to be’ to deal with China’s coronavirus
Now, with word of the first U.S. patient to contract the new virus that has killed 17 people in China comes the ...
Kellogg’s to cut wheat, oats treated with Bayer’s Roundup herbicide from supply chain by 2025
Kellogg’s, the multinational food manufacturer based in Battle Creek, Mich., is taking a stand. But very quietly. At the end ...
